Experts have urged the Philippine government to expedite the approval of a new-generation of dengue vaccine, amid the rising ...

Dengue cases in the country have declined for more than 10 straight weeks, the Department of Health (DOH) reported on Tuesday, June 17.However, the ...

There is no specific medicine for dengue yet. If ongoing Phase III trials yield positive results, an effective, affordable & ...

Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country ...

In response to ASEAN Dengue Day on June 15, a talk show was held on June 14 in Hanoi to discuss collective disease prevention ...

While Takeda's Qdenga (TAK-003) shot is approved as a two-dose regimen to protect people from the disease in dozens of ...

Dengue fever is on the rise across Asia—and the numbers are hard to ignore. Cases have jumped by more than 500% in some countries over the past few decades.

Dr. Jennifer Bath, ImmunoPrecise Antibodies CEO commented, "This breakthrough highlights a new frontier in AI-driven biology-where discovery is rooted in the biology of a virus itself. By confirming ...

"Our vaccine has been approved in 40 countries." New vaccine offers hope in fight against disease that threatens half of world's population: 'Ensuring a sufficient vaccine supply is critical' first ...

Takeda plans to launch its dengue vaccine, Qdenga, in India by next year through a manufacturing partnership with Biological E, aligning with the 'Make-in-India' initiative. The company aims for ...

While Takeda’s facility in Germany currently ... making Qdenga one of the most comprehensively studied dengue vaccines to date. In May 2024, the World Health Organization (WHO) granted Qdenga ...

Takeda, a global pharmaceutical leader, is celebrating a decade in Vietnam, emphasizing its commitment to improving healthcare through innovative solutions, strategic partnerships, and the recent ...